Development Pipeline

Technologies Indications
R&D Pre-clinical Phase I Phase II Phase III MA / NDS
Cell therapies
HepaStem ACLF (IM)
         
HepaStem NASH / Fibrosis
         
HepaStem Hemophilia A / B
         
H2Stem
         
Heparesc Urea Cycle Disorder
         
Technologies Indications
R&D Pre-clinical Phase I Phase II Phase III MA / NDS
Biologicals
Atrosimab NASH/Fibrosis
         
Sign Up